{"name":"Australian & New Zealand Children's Haematology/Oncology Group","slug":"australian-new-zealand-children-s-haematology-oncology-group","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Opdualag","genericName":"Opdualag","slug":"opdualag","indication":"Advanced melanoma with tumour cell PD-L1 expression below 1%","status":"marketed"}]}],"pipeline":[{"name":"Opdualag","genericName":"Opdualag","slug":"opdualag","phase":"marketed","mechanism":"Lymphocyte activation gene 3 protein","indications":["Advanced melanoma with tumour cell PD-L1 expression below 1%","Unresectable or metastatic melanoma"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxQOGRPNFozazAtRmtVVFgzd0VXY3lYWElSX0JfQ1VUbXlCR3hLM0txeWxrVi1tR214QlJQb0s0WGh6WXl0Y2Z5RmIyV0pQTXBaRXBHenJXNF9FXzZaOW84WWRDOTM0VGl4dmVPSjk2QVpiaXkwR2lNdlB1TzRzVENjVGgyWTNlMmlCc19yajdnbi1WdWNwMEdrYjhzTlkzdE5TOUFIUlBZSm4?oc=5","date":"2026-02-13","type":"trial","source":"BioWorld News","summary":"Australia launches world-first pediatric mRNA brain cancer trial - BioWorld News","headline":"Australia launches world-first pediatric mRNA brain cancer trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9wFBVV95cUxNbEc3WEQxM0V0blc4Y1NOb04wY2E1dDRvWldjd1lrNlZUdmJLcGtGUFJaNTdrRjBFWEZLMFBYNHdDNkRDVk1Ma0ctRGVqS1B6TDR2TVo3TzhFSHFvdGJ1bVhEem94UFdzdVNWbUhoM3hqSjRsTjM5dTFZVXpEaDVlX1NWTTVlZ2Z4aFk2aHB1T1ZjWFFpNDN6WFp2WldjUi15eERGdlRHWEU1T1p1SVgzME1IRWY2MlNTTnY2RlJwOEYyemY2d1FsWjdORUhFV1lDY0ZKZVYwZDhNYjdBT0lmb3VJTmRlZ1pLbTczVXVuUERtZk84dWRr?oc=5","date":"2026-02-06","type":"trial","source":"BioPharma APAC","summary":"Australian World First Paediatric mRNA Brain Cancer Trial Signals Expansion Opportunity For Canada And The United States - BioPharma APAC","headline":"Australian World First Paediatric mRNA Brain Cancer Trial Signals Expansion Opportunity For Canada And The United States","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0gFBVV95cUxQNnY4UWozZ01Qd0dqYU55SEoyblNqZ3ZsN0tsMFQ1Wk5nQWdYNW5SNE9NUGZWMUU5VVVHSmthOEp2QVRHeXdZemNQLUQtd1ZacXV0RExrbDlDTV96R3RyY0RUWUItdFVpM19GcC1yN0dmbkxVVVJoN3RnVUZUTWo3SFB6eldjeWQ2d1VnR2t1OEh4aDlILVZRbklwUEc0LVk0NUxCWG1veFVJelE0eDRXMjJ2R1ZYM1R2WUZVQkk1dmYtZlJ3UExrbWxqbjFCNkIwbWc?oc=5","date":"2026-02-05","type":"trial","source":"BioSpectrum Asia","summary":"Australian trial of personalised vaccines to treat children with deadly brain cancers - BioSpectrum Asia","headline":"Australian trial of personalised vaccines to treat children with deadly brain cancers","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxNemVic1lEVEpWVE1HS3FOa2pOM0JETjRfY3ZrOV9Lc0trYWY3emtwYVktTUhScUxDM1VLcC1BLThRSlRRTEo5cnhuR1ZvUFMwVm1TNVFYUkgyZTZKR01WNG1ickRqWGx3R0NPX01OWHV4NV94S2VZQmhld0w4M0diRDBTdnlhTUMxRmhsdTlEVjRuQQ?oc=5","date":"2026-02-02","type":"trial","source":"Australian Broadcasting Corporation","summary":"Trial for brain cancer vaccines supported by devastated family of 9yo boy - Australian Broadcasting Corporation","headline":"Trial for brain cancer vaccines supported by devastated family of 9yo boy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZEFVX3lxTE5Ud2tlUUpGUE1TZXdON2pwQXAxVldibG9tcjFaS0ZqdmxHQXR3cDRFTU5RMTFYeFVaUU1rcEsyT2Nqc1FPdUZvWHI0TE9lcjR6UVFjcHRDMHNLWTVwbEFEVy13YVU?oc=5","date":"2026-01-23","type":"regulatory","source":"Wiley Online Library","summary":"Blinatumomab in de novo AYA ALL—Results of the Australasian Leukaemia and Lymphoma Group ALL09 “SUBLIME” study - Greenwood - 2026 - HemaSphere - Wiley Online Library","headline":"Blinatumomab in de novo AYA ALL—Results of the Australasian Leukaemia and Lymphoma Group ALL09 “SUBLIME” study - Greenwo","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizgFBVV95cUxNOS00Qk1BQVU1NTFkR1dKSnpoVlFPQjdEY09mRHljckp5RWFYMENXbTM3U0dPaU9xekkwSUFxU1cwZ0tMRVpPeG1MSlZsM0lJbnh1RHcyNmdNQ3hYSEhOUmZDaDBMWFdSaHVuWVM3NTQwWUJ3Z0R5SVU5MEVLZThtRXFkbGNkekllZGQ3RjFzMDdCVzFKbzVZVlU2c0loaUNfY29zVnZUVnR2d3gyaDZ4bHFheDVNWldRaWNVTzNYZGtnZ1NrRDJZUXdmTFgzdw?oc=5","date":"2025-05-29","type":"regulatory","source":"PR Newswire","summary":"NEW THERAPY FOR CHILDREN WITH GROWTH HORMONE DEFICIENCY APPROVED IN AUSTRALIA - PR Newswire","headline":"NEW THERAPY FOR CHILDREN WITH GROWTH HORMONE DEFICIENCY APPROVED IN AUSTRALIA","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTFBYTUsyNktlUGxpTk15bEItYWNJMmtoY1YyRTZKWXlGcXZ1Q0haWVduRGxiUEZTUTBjRFFTWlZQa2ZWNkdVMVVOVGpsUFdWUEg0bGhCV0w4ZVVvMUh5RElmdmZQZWRmdzZ6U2xNeElFVW5OdmQxRlNqX2U3QlI?oc=5","date":"2025-01-02","type":"trial","source":"Clinical Trials Arena","summary":"University of Birmingham launches trial for paediatric B-NHL treatment in UK - Clinical Trials Arena","headline":"University of Birmingham launches trial for paediatric B-NHL treatment in UK","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxOaF82TUR4b3Q4THhJc0YwbWJ1bXBZRlhBS3BwcDdidVNmcC10NVg2Q1BBb0tWelBMUWV4NmNTWkQ5VE5seGRlRmVKRGxkVUNUYXl3ZnZySW1QWU5qandndEEtR3h0ckpuMm1lcDRWQVJsRkdzSUhqX1I1Q200aUljQnMzVjNJODVjRVNHa05QS0ZHVTVFY1FLYVo2ejhTWVdZMXc?oc=5","date":"2024-12-09","type":"trial","source":"Applied Clinical Trials","summary":"Landmark Phase III Trial Results Show Blincyto Plus Chemotherapy Boosts Three-Year Survival in Pediatric Standard-Risk B-Cell ALL - Applied Clinical Trials","headline":"Landmark Phase III Trial Results Show Blincyto Plus Chemotherapy Boosts Three-Year Survival in Pediatric Standard-Risk B","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFBqUWNWdTNwM1JWTXYxcmxxQ1VfMUN2RWxvT3BFSWtLN0J4N0NiT0tHb2NvWlNDVnlXcGJPRXhkaFU3QWdRMFZjbGs0WFpqMUZNamlwQjQ4dE9SdnpwTko4?oc=5","date":"2024-06-06","type":"pipeline","source":"Nature","summary":"Precision-guided treatment in high-risk pediatric cancers - Nature","headline":"Precision-guided treatment in high-risk pediatric cancers","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxOakludnBmUDYzZGZ6dkRyWG1oRk92M25oZlpSeUFhQ0ZjV0JRTk5fSDNKVjMxZXpRTFhDdTRzejBfZS1zSmNGeVA1RGVYdkwyaHpCd0RiYl80UG11T0N0ay1OTzVwUTA4TEJTSU85QVFzRkw3c2JfU3pLY0NLay04Y2ZHQXNkcEtyMUEzQTlMeFdPeWNybVZ0a21SeHZEeU95QjBMbWZfaExWQ0hBVnVpR0VWYU9jUWtEQWlqdkd3?oc=5","date":"2024-05-13","type":"regulatory","source":"The Medical Journal of Australia","summary":"Management of patients with diffuse intrinsic pontine glioma in Australia and New Zealand: Australian and New Zealand Children's Haematology/Oncology Group position statement - The Medical Journal of ","headline":"Management of patients with diffuse intrinsic pontine glioma in Australia and New Zealand: Australian and New Zealand Ch","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswJBVV95cUxOa2dGWEVIbVFNZl9YLWZBZ1dKV2dPMUxWOVhDcjc3dDNmNFZmdWs2RDdOdkFVX09pb3d3VXA3d1U3czdrcVJJSzdqMG9fb2VzNnd0Rks0dFBwYVNHVkNXUnFoMGpwdVBhQzFuWW5xckt3S2lkOXhhVkwwOXRkbF9Sc2J0VDFNb3k0aEk4VXc5eG9nVllZckJNT29maXQ0TDJ0cGVrQ1YtcnBJSEZwUWFNeWVkMHVBdXhQNlgtQ1J0RGdiMDZpQ3FDTVliLTItak1GaS1naHFnbVRObEMzS0J0YWQ1ZkNyRHpoTmJzbWx2d1QtU0NubGVyUUdiWTY1SUlHaGhhd0lMTVlFUDg3MjE2WUlGU3lTWk9fTC1WWl83VVBBRTBLcG5heEF6ajBXRlJ1aXdJ?oc=5","date":"2023-04-11","type":"deal","source":"PR Newswire","summary":"Specialised Therapeutics signs partnership agreement with Akeso Inc. and CTTQ-Akeso to commercialise new anti-PD1 antibody in Australia and Southeast Asia - PR Newswire","headline":"Specialised Therapeutics signs partnership agreement with Akeso Inc. and CTTQ-Akeso to commercialise new anti-PD1 antibo","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwJBVV95cUxPUE5iTG9na0tzWm9WUGQ5WWNaMXo2VEdxYXc3NDlwaS1ENWNKTUVSUVVLS1dJVC1iRWxnTUVPbXdwNkpUbnVyU2RJclNYZHVGYm9OOWlTZXIxRTlnYlJCQlZvNlI4eGZNcFM5aDQ1alg0b1JTMHZZbTBnUGl1VGJhUGhvU0hWVzBwT2ViUTk5dnpiUXJHVEdmb192OVJxYjVqZEM2MFppY2d5SVZXemd0OHA0MHZ2ZG9zeDk0bW9nbEFjU2Z5RzE4OERWVG1NRnpZZDNaekluMmdUb1NLdVNiSmQxZ20zZFh2X0dScFpCeHFfZkxMTU1qNXQzZ0N2N0Rvd2ljNy1fMnBiSzNHM205bzBUaFJ2MTQ?oc=5","date":"2023-03-06","type":"trial","source":"Proactive financial news","summary":"Kazia Therapeutics forms clinical collaboration for Australian Phase 2 study of paxalisib, targeting childhood cancers - Proactive financial news","headline":"Kazia Therapeutics forms clinical collaboration for Australian Phase 2 study of paxalisib, targeting childhood cancers","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}